The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon.
about
Health Disparities in the Immunoprevention of Human Papillomavirus Infection and Associated MalignanciesHPV genotype distribution in Brazilian women with and without cervical lesions: correlation to cytological dataUptake of the human papillomavirus vaccine in Kenya: testing the health belief model through pathway modeling on cohort data.The use of urine in the follow-up of HPV vaccine trials.Genotype distribution characteristics of multiple human papillomavirus in women from the Taihu River Basin, on the coast of eastern China.Prevalence of HPV infection among 28,457 Chinese women in Yunnan Province, southwest ChinaRole of vaccination in the sustainability of healthcare systems.US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccinesAn overview of early investigational drugs for the treatment of human papilloma virus infection and associated dysplasia.Making Sense of Cervical Cancer Screening Guidelines and Recommendations.Expanded strain coverage for a highly successful public health tool: prophylactic 9-valent human papillomavirus vaccine.Human Papillomavirus Associated Cancers of the Head and Neck: An Australian Perspective.Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries.High prevalence of human papillomavirus type 58 in HIV infected men who have sex with men: A preliminary report in Central Italy.Candidate biomarkers in the cervical vaginal fluid for the (self-)diagnosis of cervical precancer.Prevalence and type distribution of human papillomavirus (HPV) in Malaysian women with and without cervical cancer: an updated estimate.Development and characterization of an HPV18 detection kit using two novel HPV18 type-specific monoclonal antibodies
P2860
Q26770541-7564BF8E-EA64-419F-97ED-E83FD3CF687FQ31121182-D2D1F04E-C31F-4974-91CB-B48D4D79A073Q31142465-92E7CECB-FDE7-4F33-82D1-D7AC878C4E97Q35887553-CCA2B896-2C24-4722-9DD8-EB04B9C5E78FQ36321058-7D147479-EE91-46C7-986D-269691885419Q36574466-E7273328-5AF5-4B19-A391-39CD9FB00301Q36714717-8F3266FA-A101-4CD5-BC23-180128A07E82Q36817074-9F5F8150-BB6D-4E28-A7BF-D95297F9FE78Q38386055-EB89B43F-3C27-4BEC-977F-9579291CE35DQ38607427-7A34762A-0245-4661-B85B-5202D00CEB2AQ38682763-9B1DF32D-4AE3-4925-9167-456C0E3BBF91Q39125435-42385B18-4EB2-4341-9B67-4DD88B2A5202Q40569845-FF4FF0F9-C8B2-41B3-B4F3-07D634A5A5BBQ40952825-105D4E62-2116-4A07-9158-06B76FE5F800Q47397671-3AD92879-7023-4660-90B3-93E7A25B62CCQ54265480-3BFB3A21-1DF2-4DBA-BCD9-7BCCA2B0FEFCQ58771886-2E43FD01-FA41-4F64-91BE-2B1B63DC7DFD
P2860
The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon.
@en
type
label
The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon.
@en
prefLabel
The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon.
@en
P2860
P1476
The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon.
@en
P2093
Archana Chatterjee
P2860
P304
P356
10.1586/14760584.2014.963561
P577
2014-09-26T00:00:00Z